314 related articles for article (PubMed ID: 779020)
21. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
[No Abstract] [Full Text] [Related]
22. Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.
Andén NE
J Pharm Pharmacol; 1972 Nov; 24(11):905-6. PubMed ID: 4405656
[No Abstract] [Full Text] [Related]
23. Lack of a high affinity transport system for dopamine in the median eminence and posterior pituitary.
Demarest KT; Moore KE
Brain Res; 1979 Aug; 171(3):545-51. PubMed ID: 476488
[No Abstract] [Full Text] [Related]
24. [The role of brain dopamine].
Rybakowski J
Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234
[No Abstract] [Full Text] [Related]
25. The dopamine hypothesis of schizophrenia revisited.
van Kammen DP
Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
[No Abstract] [Full Text] [Related]
26. [Fluorescence of dopamine terminals in rat brain during reproduction of conditioned defense reactions].
Spiridonov VK
Neirofiziologiia; 1979; 11(2):171-3. PubMed ID: 440491
[No Abstract] [Full Text] [Related]
27. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
[No Abstract] [Full Text] [Related]
28. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
Sethy VH; VAN Woert MH
Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
[No Abstract] [Full Text] [Related]
29. Axonal transport in nigro-striatal and nigro-thalamic neurons: effects of medial forebrain bundle lesions and 6-hydroxydopamine.
Fibiger HC; Pudritz RE; McGeer PL; McGeer EG
J Neurochem; 1972 Jul; 19(7):1697-708. PubMed ID: 4114445
[No Abstract] [Full Text] [Related]
30. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
Matthysse S
Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
[No Abstract] [Full Text] [Related]
31. [The role of dopamine in the physiology and pathology of the basal ganglia].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
[No Abstract] [Full Text] [Related]
32. Biochemical aspects of dopamine agonists.
Kehr W; Carlsson A; Lindqvist M
Adv Neurol; 1975; 9():185-95. PubMed ID: 1146653
[No Abstract] [Full Text] [Related]
33. [Functional role and pharmacological regulation of the dopaminergic system of the brain].
Raevskiĭ KS
Vestn Ross Akad Med Nauk; 1998; (8):19-24. PubMed ID: 9771125
[TBL] [Abstract][Full Text] [Related]
34. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.
Scatton B; Boireau A; Garret C; Glowinski J; Julou L
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):169-75. PubMed ID: 13318
[No Abstract] [Full Text] [Related]
35. Mesencephalic dopamine neurons projecting to neocortex.
Lindvall O; Björklund A; Moore RY; Stenevi U
Brain Res; 1974 Dec; 81(2):325-31. PubMed ID: 4373129
[No Abstract] [Full Text] [Related]
36. Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.
Ghose S; Crook JM; Bartus CL; Sherman TG; Herman MM; Hyde TM; Kleinman JE; Akil M
Int J Neurosci; 2008 Nov; 118(11):1609-27. PubMed ID: 18853337
[TBL] [Abstract][Full Text] [Related]
37. Behavioral effects of central catecholamines: concluding remarks.
Vogt M
J Psychiatr Res; 1974; 11():183-4. PubMed ID: 4461789
[No Abstract] [Full Text] [Related]
38. Melanin formation by human brain in vitro.
Rodgers AD; Curzon G
J Neurochem; 1975 Jun; 24(6):1123-9. PubMed ID: 1127428
[No Abstract] [Full Text] [Related]
39. Effect of metergoline on delayed response in cats and its relation to the metabolism of dopamine and serotonin in neostriatal and mesolimbic neurons.
Roberge AG; Roy JP; Boisvert C
Exp Brain Res; 1978 May; 32(1):19-30. PubMed ID: 658185
[TBL] [Abstract][Full Text] [Related]
40. New developments in the study of the mechanism of action of neuroleptics and amphetamine.
Glowinski J
J Psychiatr Res; 1974; 11():81-5. PubMed ID: 4156794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
